[Federal Register Volume 85, Number 159 (Monday, August 17, 2020)]
[Notices]
[Page 50034]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17817]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council on Drug Abuse.
The meeting will be held as a virtual meeting and is open to the
public, as indicated below. Individuals who plan to view the virtual
meeting and need special assistance or other reasonable accommodations
to view the meeting, should notify the Contact Person listed below in
advance of the meeting. The open session will be videocast and can be
accessed from the NIH Videocasting and Podcasting website (http://videocast.nih.gov/).
A portion of this meeting will be closed to the public in
accordance with the provisions set forth in sections 552b(c)(4) and
552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Advisory Council on Drug Abuse.
Date: September 10, 2020.
Closed: 11:00 a.m. to 12:15 p.m.
Agenda: To review and evaluate grant applications.
Open: 12:45 p.m. to 4:30 p.m.
Agenda: Presentations and other business of the Council.
Place: National Institutes of Health, National Institute on Drug
Abuse, Neurosciences Center Building, 6001 Executive Boulevard,
Rockville, MD 20852 (Virtual Meeting).
Contact Person: Susan R.B. Weiss, Ph.D., Director, Division of
Extramural Research, Office of the Director, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive Boulevard, NSC, Room 5274, MSC
9591, Rockville, MD 20892, 301-443-6487, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: August 11, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-17817 Filed 8-14-20; 8:45 am]
BILLING CODE 4140-01-P